ReviewCancers2021
Targeted Neoadjuvant Therapies in HR+/HER2-Breast Cancers: Challenges for Improving pCR.
Nandini Dey et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this paperpooled itcites it
ReviewCancers2021
Nandini Dey et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.